14 Biggest Mid-Day Gainers For Tuesday

Aldeyra Therapeutics Inc ALDX surged 57.9 percent to $6.63. Aldeyra Therapeutics disclosed 'positive' results from dry eye disease Phase 2a clinical trial.
Aethlon Medical, Inc. AEMD shares climbed 50.6 percent to $3.01 after the company disclosed Expedited Access Pathway designation from the FDA to accelerate US access to Hemopurifier.
Quotient Ltd QTNT shares gained 28.1 percent to $4.75 after the company reports results from latest MosaiQ performance evaluation studies prior to commencing verification and validation studies.
SAExploration Holdings, Inc. SAEX shares rose 20 percent to $2.87.
Inovalon Holdings Inc INOV shares surged 17.6 percent to $17.23. Morgan Stanley upgraded Inovalon Holdings from Underweight to Equal-Weight and raised the price target from $9.00 to $14.00.
Forterra Inc FRTA shares rose 15.8 percent to $4.90.
Akari Therapeutics PLC (ADR) AKTX shares surged 10 percent to $5.29.
Citius Pharmaceuticals Inc CTXR shares rose 9.5 percent to $3.50.
Baozun Inc (ADR) BZUN shares climbed 8.3 percent to $34.82.
Pier 1 Imports Inc PIR shares rose 6.8 percent to $4.64.
MasTec, Inc. MTZ climbed 6.1 percent to $43.40. Deutsche Bank upgraded MasTec from Hold to Buy.
Comerica Incorporated CMA rose 3.8 percent to $69.29. Piper Jaffray upgraded Comerica from Neutral to Overweight.
Alcoa Corp AA surged 3.2 percent to $44.99. Deutsche Bank upgraded Alcoa from Hold to Buy.
Teva Pharmaceutical Industries Ltd (ADR) TEVA gained 3.1 percent to $19.07 after surging 19.35 percent on Monday. The company reported the sale of PARAGARD to CooperSurgical for $1.1 billion in cash.